Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag A trial found adding low-dose megestrol to anti-estrogen therapy slowed tumor growth in post-menopausal women with ER-positive breast cancer.

flag A Cambridge-led trial found that adding low-dose megestrol acetate, a synthetic progesterone, to anti-estrogen therapy slowed tumor growth in post-menopausal women with ER-positive breast cancer. flag In the PIONEER study, 198 patients receiving the combination treatment showed greater reductions in tumor growth than those on anti-estrogen therapy alone. flag The drug, already used to manage treatment side effects like hot flashes, may improve adherence and outcomes. flag While further research is needed, the results suggest megestrol could offer both symptom relief and direct anti-cancer benefits.

3 Articles

Further Reading